Margarida Duarte-Araujo
Overview
Explore the profile of Margarida Duarte-Araujo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Esteves-Monteiro M, Ferreira-Duarte M, Vitorino-Oliveira C, Costa-Pires J, Oliveira S, Matafome P, et al.
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39596183
Gastrointestinal complications of diabetes are often overlooked, despite affecting up to 75% of patients. This study innovatively explores local glutathione levels and morphometric changes in the gut of Goto-Kakizaki (GK)...
2.
Ferreira-Duarte M, Oliveira L, Quintas C, Dias-Pereira P, Sousa T, Magro F, et al.
J Gastroenterol Hepatol
. 2024 Jul;
39(9):1885-1894.
PMID: 38967213
Background And Aim: Inflammatory bowel disease is challenging to diagnose. Fecal biomarkers offer noninvasive solutions. The renin-angiotensin-aldosterone system is implicated in intestinal inflammation. Angiotensin-converting enzyme (ACE) and angiotensin-converting enzyme 2...
3.
Reis-Mendes A, Ferreira M, Padrao A, Duarte J, Duarte-Araujo M, Remiao F, et al.
Inflammation
. 2023 Oct;
47(1):264-284.
PMID: 37833616
Doxorubicin (DOX) is a topoisomerase II inhibitor used in cancer therapy. Despite its efficacy, DOX causes serious adverse effects, such as short- and long-term cardiotoxicity. This work aimed to assess...
4.
Ferreira-Duarte M, Lopes I, Morato M, Duarte-Araujo M
Lab Anim
. 2023 Sep;
58(2):160-163.
PMID: 37712834
Voluntary oral drug administration using sweet substances promotes rodents' therapeutic compliance while reducing stress induced by forced drug administration. We aimed to test whether rats would willingly eat strawberry jam...
5.
Reis-Mendes A, Ferreira M, Duarte J, Duarte-Araujo M, Remiao F, Carvalho F, et al.
Arch Toxicol
. 2023 Sep;
97(12):3163-3177.
PMID: 37676301
Doxorubicin (DOX) is a potent chemotherapeutic agent used against several cancer types. However, due to its cardiotoxic adverse effects, the use of this drug may be also life-threatening. Although most...
6.
Ferreira-Duarte M, Tonin F, Duarte-Araujo M, Fernandez-Llimos F, Morato M
Fundam Clin Pharmacol
. 2023 Jul;
37(6):1139-1152.
PMID: 37394277
Background: The renin-angiotensin system (RAS) has been associated with inflammatory bowel disease (IBD), supporting translational relevance of RAS blockers. Comparability of study design/outcomes is fundamental for data analysis/discussion. Objectives: We...
7.
Brandao S, Reis-Mendes A, Duarte-Araujo M, Neuparth M, Rocha H, Carvalho F, et al.
Biomolecules
. 2023 Jun;
13(6).
PMID: 37371499
Doxorubicin (DOX) and mitoxantrone (MTX) are classical chemotherapeutic agents used in cancer that induce similar clinical cardiotoxic effects, although it is not clear if they share similar underlying molecular mechanisms....
8.
Ferreira-Duarte M, Oliveira L, Quintas C, Esteves-Monteiro M, Duarte-Araujo M, Sousa T, et al.
Neurogastroenterol Motil
. 2023 Apr;
35(9):e14598.
PMID: 37052403
Background: Angiotensin-converting enzyme (ACE) and ACE2 are two major enzymes of the renin-angiotensin-aldosterone system (RAAS), which control the formation/degradation of angiotensin (Ang) II and Ang1-7, regulating their opposite effects. We...
9.
Esteves-Monteiro M, Menezes-Pinto D, Ferreira-Duarte M, Dias-Pereira P, Morato M, Duarte-Araujo M
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36362021
Diabetes mellitus (DM) is a chronic progressive metabolic disorder associated with several gastrointestinal complications, affecting up to 75% of patients. Knowing that Angiotensin II (AngII) also regulates intestinal contraction, we...
10.
Dionisio F, Araujo A, Duarte-Araujo M, Bastos M, Guedes de Pinho P, Carvalho F, et al.
Arch Toxicol
. 2022 Jan;
96(2):653-671.
PMID: 35088106
Cyclophosphamide is a widely used anticancer and immunosuppressive prodrug that unfortunately causes severe adverse effects, including cardiotoxicity. Although the exact cardiotoxic mechanisms are not completely understood, a link between cyclophosphamide's...